United States Surgical Corporation Sustainability Profile
United States Surgical Corporation, often referred to as U.S. Surgical, is a prominent player in the medical device industry, headquartered in the United States. Founded in the early 1980s, the company has established itself as a leader in surgical products, particularly in the development of innovative stapling devices and minimally invasive surgical solutions. With a strong operational presence across North America and Europe, U.S. Surgical is renowned for its commitment to enhancing surgical outcomes through advanced technology. The company’s core offerings include a range of surgical staplers and related instruments, which are distinguished by their precision and reliability. U.S. Surgical has achieved significant milestones, including numerous patents and recognitions for its contributions to surgical innovation, solidifying its market position as a trusted provider in the healthcare sector.
DitchCarbon Score
How does United States Surgical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
United States Surgical Corporation's score of 50 is higher than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
United States Surgical Corporation, headquartered in the US, currently does not have specific carbon emissions data available for recent years. However, the company is a current subsidiary of Medtronic plc, which influences its climate commitments and emissions reporting. As part of its corporate family relationship with Medtronic, United States Surgical Corporation adheres to the sustainability initiatives and targets set by Medtronic. This includes participation in the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP), both of which are aimed at reducing greenhouse gas emissions across their operations. While specific reduction targets for United States Surgical Corporation are not detailed, the overarching commitments from Medtronic include a focus on reducing Scope 1, 2, and 3 emissions, aligning with industry standards for climate action. The company is also involved in various sustainability initiatives, although specific details on these initiatives are not provided. In summary, while United States Surgical Corporation does not report its own emissions data, it is committed to the climate goals and reduction strategies cascaded from its parent company, Medtronic plc, reflecting a broader commitment to sustainability within the healthcare sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Scope 1 | 74,992,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 |
| Scope 2 | 269,008,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | 000,000,000 | 000,000,000 | - |
How Carbon Intensive is United States Surgical Corporation's Industry?
How Carbon Intensive is United States Surgical Corporation's Location?
United States Surgical Corporation's Scope 3 Categories Breakdown
United States Surgical Corporation's Scope 3 emissions, which increased by 48% last year and increased by approximately 48% since 2021, demonstrating supply chain emissions tracking. Most of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 55% of total emissions under the GHG Protocol, with "Downstream Transportation & Distribution" being the largest emissions source at 47% of Scope 3 emissions.
Top Scope 3 Categories
United States Surgical Corporation's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
United States Surgical Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
